The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders

Journal of Autoimmune Diseases

Volumn 4, Issue , 2007, Pages

  Papamichalis, Panagiotis A ^a   Zachou, Kalliopi ^a   Koukoulis, George K ^a   Veloni, Aikaterini ^a   Karacosta, Efthimia G ^a   Kypri, Lampros ^a   Mamaloudis, Ioannis ^a   Gabeta, Stella ^a   Rigopoulou, Eirini I ^a   Lohse, Ansgar W ^b   Dalekos, George N ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHEMICAL ANALYSIS; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROLOGY;

EID: 34547638781     PISSN: None     EISSN: 17402557     Source Type: Journal    
DOI: 10.1186/1740-2557-4-3     Document Type: Article

References (48)

1. Autoimmune hepatitis, from mechanisms to therapy. MP Manns A Vogel, Hepatology 2006 43 2 Suppl 1 S132 S144 10.1002/hep.21059 16447290
2. Autoimmune hepatitis. EL Krawitt, N Engl J Med 2006 354 54 66 10.1056/NEJMra050408 16394302
3. Autoimmune liver disease. AJ Czaja, Curr Opin Gastroenterol 2006 22 234 240 10.1097/01.mog.0000218959.48064.7f 16550037
4. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. K Zachou E Rigopoulou GN Dalekos, J Autoimmune Dis 2004 1 1 2 15679907 10.1186/1740-2557-1- 2
5. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. F Alvarez PA Berg FB Bianchi L Bianchi AK Burroughs EL Cancado RW Chapman WG Cooksley AJ Czaja VJ Desmet PT Donaldson AL Eddleston L Fainboim J Heathcote JC Homberg JH Hoofnagle S Kakumu EL Krawitt IR Mackay RN MacSween WC Maddrey MP Manns IG McFarlane KH Meyer zum Buschenfelde M Zeniya, J Hepatol 1999 31 929 938 10.1016/S0168-8278(99)80297-9 10580593
6. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? S Yatsuji E Hashimoto H Kaneda M Taniai K Tokushige K Shiratori, J Gastroenterol 2005 40 1130 1138 10.1007/s00535-005-1711-z 16378177
7. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. LA Adams KD Lindor P Angulo, Am J Gastroenterol 2004 99 1316 1320 10.1111/j.1572-0241.2004.30444.x 15233671
8. Histological findings in chronic hepatitis C with autoimmune features. AJ Czaja HA Carpenter, Hepatology 1997 26 459 466 10.1002/hep.510260229 9252159
9. Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. C Liaskos E Rigopoulou K Zachou S Georgiadou N Gatselis R Papamihali GN Dalekos, J Autoimmun 2005 24 251 260 10.1016/j.jaut.2005.01.016 15848048
10. Meeting report: International Autoimmune Hepatitis Group. PJ Johnson IG McFarlane, Hepatology 1993 18 998 1005 10.1002/hep.1840180435 8406375
11. Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection. GN Dalekos K Achenbach D Christodoulou GK Liapi EK Zervou DA Sideris EV Tsianos, Heart 1998 80 270 275 9875087
12. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. K Zachou C Liaskos DK Christodoulou M Kasdasi G Papadamou N Gatselis EV Tsianos GN Dalekos, Eur J Clin Invest 2003 33 161 168 10.1046/j.1365-2362. 2003.01110.x 12588291
13. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections. M Satra GN Dalekos P Kollia N Vamvakopoulos A Tsezou, J Viral Hepat 2005 12 488 493 10.1111/j.1365-2893.2005.00550.x 16108763
14. A prospective evaluation of dermatologic side effects during alpha-interferon therapy for chronic viral hepatitis. GN Dalekos D Christodoulou KG Kistis EK Zervou J Hatzis EV Tsianos, Eur J Gastroenterol Hepatol 1998 10 933 939 9872615
15. Cryoglobulinemia due to chronic viral hepatitis infections is not a major problem in clinical practice. DK Christodoulou GN Dalekos MH Merkouropoulos KG Kistis G Georgitsi E Zervou EV Tsianos, Eur J Intern Med 2001 12 435 441 10.1016/S0953-6205(01)00151-0 11557330
16. Interferon-alpha treatment of children with chronic hepatitis D virus infection : the Greek experience. GN Dalekos E Galanakis E Zervou M Tzoufi PD Lapatsanis EV Tsianos, Hepatogastroenterology 2000 47 1072 1076 11020882
17. EASL International Consensus Conference on Hepatitis B, 13-14 September, 2002, Geneva, Switzerland. Consensus statement (Short version). The EASL jury, J Hepatol 2003 38 533 540 12663250
18. Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. DS Kyriakou MG Alexandrakis K Zachou F Passam NE Stathakis GN Dalekos, J Hepatol 2003 39 679 685 10.1016/S0168-8278(03)00387-8 14568247
19. Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. A Tsikrikoni DS Kyriakou E Rigopoulou MG Alexandrakis K Zachou F Passam GN Dalekos, J Hepatol 2005 42 393 399 10.1016/j.jhep.2004.11.023 15710223
20. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. K Zachou C Liaskos E Rigopoulou S Gabeta P Papamichalis N Gatselis S Georgiadou GN Dalekos, Clin Immunol 2006 119 203 212 10.1016/j.clim.2006.01.002 16500150
21. Chronic cholestatic diseases. R Poupon O Chazouilleres RE Poupon, J Hepatol 2000 32 129 140 10.1016/S0168-8278(00)80421-3 10728800
22. Two different subtypes of antimitochondrial antibodies are associated with primary biliary cirrhosis: identification and characterization by radioimmunoassay and immunoblotting. M Manns G Gerken A Kyriatsoulis C Trautwein K Reske K-H Meyer zum Büschenfelde, Hepatology 1987 5 893 899 10.1002/hep.1840070517
23. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. BA Neuschwander-Tetri SH Caldwell, Hepatology 2003 37 1202 1219 10.1053/jhep.2003.50193 12717402
24. Diagnosis of primary sclerosing cholangitis - autoimmune hepatitis overlap syndrome: to score or not to score? O Chazouilleres, J Hepatol 2000 33 661 663 10.1034/j.1600-0641.2000.033004661.x 11059874
25. Hepatic overlap syndromes. U Beuers, J Hepatol 2005 42 S93 S99 10.1016/j.jhep.2004.11.009 15777577
26. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome : clinical features and response to therapy. O Chazouilleres D Wendum L Serfaty S Montembault O Rosmorduc R Poupon, Hepatology 1998 28 296 301 10.1002/hep.510280203 9695990
27. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece. GN Dalekos E Makri S Loges P Obermayer-Straub K Zachou T Tsikrikas E Schmidt G Papadamou MP Manns, Eur J Gastroenterol Hepatol 2002 14 35 42 10.1097/00042737-200201000-00007 11782573
28. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment. GN Dalekos H Wedemeyer P Obermayer-Straub A Kayser A Barut H Frank MP Manns, J Hepatol 1999 30 366 375 10.1016/S0168-8278(99)80092-0 10190716
29. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. D Vergani F Alvarez FB Bianchi EL Cancado IR Mackay MP Manns M Nishioka E Penner, J Hepatol 2004 41 677 683 10.1016/j.jhep.2004.08.002 15464251
30. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. GN Dalekos K Zachou C Liaskos N Gatselis, Eur J Intern Med 2002 13 293 303 10.1016/S0953-6205(02)00089-4 12144908
31. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study. NK Gatselis SP Georgiadou N Tassopoulos K Zachou C Liaskos A Hatzakis GN Dalekos, World J Gastroenterol 2005 11 482 487 15641130
32. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis. AQ Farias LL Goncalves PL Bittencourt ES De Melo CP Abrantes-Lemos G Porta MC Nakhle FJ Carrilho EL Cancado, J Gastroenterol Hepatol 2006 21 887 893 10.1111/j.1440-1746.2006.04130.x 16704541
33. Simplified diagnostic criteria for autoimmune hepatitis. EM Hennes M Zeniya AJ Czaja A Pares G Dalekos E Krawitt PL Bittencourt KM Boberg H Hofer FB Bianchi A Victor HP Dienes BE de Torres PR Galle AW Lohse, Hepatology 2005 42 295A
34. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. F Cassani M Cataleta P Valentini P Muratori F Giostra R Francesconi L Muratori M Lenzi G Bianchi D Zauli FB Bianchi, Hepatology 1997 26 561 566 10.1002/hep.510260305 9303483
35. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. M Lenzi S Bellentani G Saccoccio P Muratori F Masutti L Muratori F Cassani FB Bianchi C Tiribelli, Gut 1999 45 435 441 10446115
36. Immunologic and viral markers in the circulation of anti-HIV negative heroin addicts. GN Dalekos MN Manoussakis E Zervou EV Tsianos HM Moutsopoulos, Eur J Clin Invest 1993 23 219 225 7684680
37. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. P Muratori L Muratori M Guidi A Granito M Susca M Lenzi FB Bianchi, Clin Infect Dis 2005 40 501 507 10.1086/427285 15712070
38. Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis. SJ Cotler K Kanji A Keshavarzian DM Jensen S Jakate, J Clin Gastroenterol 2004 38 801 804 10.1097/01.mcg.0000139072.38580.a0 15365409
39. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. P Loria A Lonardo F Leonardi C Fontana L Carulli AM Verrone A Borsatti M Bertolotti F Cassani A Bagni P Muratori D Ganazzi FB Bianchi N Carulli, Dig Dis Sci 2003 48 2173 2181 10.1023/B:DDAS.0000004522. 36120.08 14705824
40. Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics. SD Lytton A Helander ZQ Zhang-Gouillon K Stokkeland R Bordone S Arico E Albano SW French M Ingelman-Sundberg, Mol Pharmacol 1999 55 223 233 9927612
41. Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver disease. Y Ma M Meregalli S Hodges N Davies DP Bogdanos S Fargion G Fiorelli D Vergani, Int J Immunopathol Pharmacol 2005 18 173 182 15698522
42. The international autoimmune hepatitis score in chronic hepatitis C. RC Dickson MJ Gaffey MB Ishitani TP Roarty CJ Driscoll SH Caldwell, J Viral Hepat 1997 4 121 128 9097268
43. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. HR van Buuren HJE van Hoogstraten T Terkivatan SW Schalm FP Vleggaar, J Hepatol 2000 33 543 548 10.1034/j.1600-0641.2000.033004543.x 11059858
44. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. JA Talwalkar JC Keach P Angulo KD Lindor, Am J Gastroenterol 2002 97 1191 1197 10.1111/j.1572-0241.2002.05703.x 12014727
45. Frequency and nature of the variant syndromes of autoimmune liver disease. AJ Czaja, Hepatology 1998 28 360 365 10.1002/hep.510280210 9695997
46. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. M Kaya P Angulo KD Lindor, J Hepatol 2000 33 537 542 10.1034/j.1600-0641.2000.033004537.x 11059857
47. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. KM Boberg O Fausa T Haaland E Holter OJ Mellbye A Spurkland E Schrumpf, Hepatology 1996 23 1369 1376 10.1002/hep.510230612 8675153
48. Autoimmune hepatitis and its variant syndromes. Z Ben-Ari AJ Czaja, Gut 2001 49 589 594 11559660 10.1136/gut.49.4.589